Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxifloxacin Triple Therapy vs Levofloxacin Sequential Therapy for H. Pylori
NCT05863858Phase 3Completed
- Start
- Jun 2020
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of moxifloxacin in Helicobacter pylori infection. Started Jun 2020; status: completed.
02
Drugs
moxifloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT05863858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863858.